![Richard Steinhart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Steinhart
Director of Finance/CFO at
BIOXCEL THERAPEUTICS, INC.
Net worth: 83 510 $ as of 2026-05-30
Profile
Richard I.
Steinhart currently serves as Independent Director at Atossa Therapeutics, Inc. since 2014, Independent Director at Actinium Pharmaceuticals, Inc. since 2013, and Senior VP, Chief Financial & Accounting Officer at BioXcel Therapeutics, Inc. since 2017.
Former positions include Independent Director at TG Therapeutics, Inc. from 2011 to 2012; Managing Director at Forest Street Capital, LLC from 1992 to 2006; Managing Director at SAE Ventures; Chief Financial Officer & Vice President at Emisphere Technologies, Inc. from 1991 to 1992; CFO, Secretary, Treasurer & Senior VP-Finance at STRATA Skin Sciences, Inc. from 2012 to 2013; Chief Financial Officer & General Partner at CW Group, Inc. from 1991 to 1992; Chief Financial Officer & Vice President at Remedy Pharmaceuticals, Inc. from 2015 to 2017.
Education includes undergraduate and MBAistration degrees from Pace University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-11 | 10,000 ( 0.12% ) | 52 300 $ | 2026-05-30 | |
| 2026-06-14 | 26,335 ( 0.18% ) | 30 812 $ | 2026-05-30 | |
| 2025-10-14 | 316 ( 0% ) | 398 $ | 2026-05-30 |
Richard Steinhart active positions
| Companies | Position | Start |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Director/Board Member | 2013-11-07 |
| ATOSSA THERAPEUTICS, INC. | Director/Board Member | 2014-03-02 |
| BIOXCEL THERAPEUTICS, INC. | Director of Finance/CFO | 2017-09-30 |
Former positions of Richard Steinhart
| Companies | Position | End |
|---|---|---|
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops molecule drugs for acute central nervous system disorders | Director of Finance/CFO | 2017-03-31 |
| STRATA SKIN SCIENCES, INC. | Director of Finance/CFO | 2013-12-30 |
| TG THERAPEUTICS, INC. | Director/Board Member | 2011-12-31 |
Forest Street Capital, LLC | Corporate Officer/Principal | 2006-04-23 |
| EMISPHERE TECHNOLOGIES, INC. | Director of Finance/CFO | 1992-04-30 |
Training of Richard Steinhart
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
59
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
STRATA Skin Sciences, Inc.
 STRATA Skin Sciences, Inc. Medical SpecialtiesHealth Technology Manufactures dermatology treatment products | Health Technology |
Atossa Therapeutics, Inc.
 Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops molecule drugs for acute central nervous system disorders | Health Technology |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Forest Street Capital, LLC | |
SAE Ventures | |
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
- Stock Market
- Insiders
- Richard Steinhart
Choose MarketScreener 
